Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-24 @ 9:28 PM
NCT ID:
NCT05932732
Eligibility Criteria:
Inclusion Criteria:
1. Healthy males and females of Fitzpatrick skin types I-VI 30-55 years of age.
2. No known medical conditions that in the investigator's opinion may interfere with study participation.
3. Agrees to abstain from starting a new skincare product for the duration of trial participation.
4. Willingness to cooperate and participate by following study requirements.
5. Individuals must sign an informed consent and photography consent.
Exclusion Criteria:
1. History of any cancer excluding fully treated basal cell carcinoma or squamous cell carcinoma in situ in the treatment area.
2. Presence of untreated precancerous lesions in the treatment area.
3. Presence of sunburn, moderate to pronounced suntan, uneven skin tone, tattoos, scars or other disfiguration in the treatment area.
4. Any cutaneous condition that may affect study adherence or ability to assess endpoints, as determined by the investigator, to include, but not limited to, uncontrolled psoriasis, atopic dermatitis, severe photodamage, and uncontrolled acne.
5. Subject is pregnant, nursing, or planning to become pregnant.
6. Significant past medical history of hepatic, hypertensive, renal, cardiac, pulmonary, digestive, hematological, neurological, or psychiatric disease, which in the opinion of the Investigator would compromise the safety of the subject.
7. Currently participating in another clinical trial.
8. History of Photo Epilepsy.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
55 Years
Study:
NCT05932732
Study Brief:
Protocol Section:
NCT05932732